INTERNATIONAL PATENT: K36 THERAPEUTICS, INC. FILES APPLICATION FOR "PIPERIDINYL-METHYL-PURINEAMINE NSD2 INHIBITOR THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING CANCER"

GENEVA, July 14 -- K36 THERAPEUTICS, INC. (1 Main StreetCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/010087) for "PIPERIDINYL-METHYL-PURINEAMINE NSD2 INHIBITOR THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING CANCER" on Jan 02, 2025. With publication no. WO/2025/147514, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CONNOLLY, Terrence Joseph (c/o K36 Therapeutics, Inc.1 Main StreetCambridge, Massachusetts 02142), QUIGLEY, Michael Travis (c/o K36 Therapeutics, Inc.1 Main StreetCambridge, Massach...